Rating History for Quince Therapeutics Inc. (QNCX) by Raymond James

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/9/2026 Tiago Fauth New Coverage Outperform
(N/A)
72.00
(N/A)
29.36
(31.73)
8.07% Details